Leukemia & Lymphoma

期刊发文

• YY1-induced LncRNA-TUG1 elevates YOD1 to promote cell proliferation and inhibit bortezomib sensitivity in multiple myeloma

  Author: Yin, Qingqing; Shen, Xianjuan; Xu, Honglei; Feng, Wei; Shi, Xiuying; Ju, Shaoqing

  Journal: LEUKEMIA & LYMPHOMA. 2023; Vol. , Issue , pp. -. DOI: 10.1080/10428194.2023.2200516

• Targeted sequencing reveals the relationship between mutations and patients' clinical indicators, blood cell counts and early progression in diffuse large-B cell lymphoma

  Author: Ma, Guangyu; Gao, Yuhuan; Jing, Xiaotong; He, Cuiying; Liu, Haisheng; Wu, Xiaolin; Gao, Zhe; Li, Yuan; Zhang, Shengnan; Zhao, Guimin

  Journal: LEUKEMIA & LYMPHOMA. 2023; Vol. 64, Issue 1, pp. 140-150. DOI: 10.1080/10428194.2022.2131427

• IFN-gamma enhances CLL cell resistance to ABT-199 by regulating MCL-1 and BCL-2 expression via the JAK-STAT3 signaling pathway

  Author: Shao, Xiaoya; Meng, Xueqiong; Yang, Haiping; Wang, Xinxin; Qin, Ling; Shen, Guomin; Xi, Xiaoping; Zhao, Huijuan; Macip, Salvador; Chen, Yixiang

  Journal: LEUKEMIA & LYMPHOMA. 2023; Vol. 64, Issue 1, pp. 71-78. DOI: 10.1080/10428194.2022.2131408

• Circulating mitochondrial DNA is associated with anemia in newly diagnosed hematologic malignancies

  Author: Yue, Liang; Li, Yu-Hang; Ma, Rui-Lin; Niu, Jing-Wen; Cui, Hong-Tu; Sun, Yao; Yun, Zhi-Min; Zhuo, Hai-Long; Wan, Lu-Ming; Li, Su-Bo; Zhang, Xue; Wu, Cheng-Jun; Hu, Liang-Ding; Tan, Ying-Xia

  Journal: LEUKEMIA & LYMPHOMA. 2023; Vol. 64, Issue 1, pp. 178-187. DOI: 10.1080/10428194.2022.2133537

• The prognostic significance of CRLF2 expression at diagnosis in adult Ph-negative B-cell precursor acute lymphoblastic leukemia

  Author: Wang, Jun; Sun, Kai; Chen, Wen-Min; Wang, Xu; Li, Ling-Di; Hao, Yue; Xu, Nan; Jiang, Hao; Xu, Lan-Ping; Wang, Yu; Zhang, Xiao-Hui; Huang, Xiao-Jun; Jiang, Qian; Qin, Ya-Zhen

  Journal: LEUKEMIA & LYMPHOMA. 2023; Vol. 64, Issue 3, pp. 698-706. DOI: 10.1080/10428194.2022.2164193

• Salinomycin sodium exerts anti diffuse large B-cell lymphoma activity through inhibition of LRP6-mediated Wnt/beta-catenin and mTORC1 signaling

  Author: Li, Liangliang; Zeng, Pengyun; Yu, Lili; Yang, Jincai; Man, Jiancheng; Zhou, Lanxia; Zhao, Li

  Journal: LEUKEMIA & LYMPHOMA. 2023; Vol. , Issue , pp. -. DOI: 10.1080/10428194.2023.2202291

• CDK7 inhibition induces apoptosis in acute myeloid leukemia cells and exerts synergistic antileukemic effects with azacitidine in vitro and in vivo

  Author: Zhang, Shuai; Feng, Ru; Bai, Jiefei; Ning, Shangyong; Xu, Xiaodong; Sun, Jie; Wu, Meng; Liu, Hui

  Journal: LEUKEMIA & LYMPHOMA. 2023; Vol. 64, Issue 3, pp. 639-650. DOI: 10.1080/10428194.2023.2169045

• Fotemustine, etoposide, cytarabine, and cyclophosphamide (FEAC) conditioning regimen for autologous stem cell transplantation in lymphoma

  Author: Lin, Meng; Wu, Xiaolong; Zhang, Lei; Li, Ling; Wang, Xinhua; Fu, Xiaorui; Sun, Zhenchang; Zhang, Xudong; Zhu, Linan; Yu, Hui; Chang, Yu; Nan, Feifei; Yan, Jiaqin; Zhou, Zhiyuan; Shi, Cunzhen; Zhang, Mingzhi; Li, Xin

  Journal: LEUKEMIA & LYMPHOMA. 2023; Vol. 64, Issue 3, pp. 605-612. DOI: 10.1080/10428194.2023.2167492